Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.76944964 |
2 | mannose metabolic process (GO:0006013) | 4.61267909 |
3 | response to peptidoglycan (GO:0032494) | 4.09532445 |
4 | cellular extravasation (GO:0045123) | 3.93462136 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.85786394 |
6 | neutrophil activation involved in immune response (GO:0002283) | 3.82642709 |
7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.67781942 |
8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49357665 |
9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.48259556 |
10 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.47190780 |
11 | germinal center formation (GO:0002467) | 3.46978741 |
12 | negative regulation of cell killing (GO:0031342) | 3.44489562 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.44489562 |
14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43270231 |
15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43270231 |
16 | modulation by symbiont of host immune response (GO:0052553) | 3.43270231 |
17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43270231 |
18 | modulation by symbiont of host defense response (GO:0052031) | 3.43270231 |
19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43270231 |
20 | regulation of ARF GTPase activity (GO:0032312) | 3.38659112 |
21 | detection of other organism (GO:0098543) | 3.36004863 |
22 | histone H3-K36 demethylation (GO:0070544) | 3.33306492 |
23 | detection of bacterium (GO:0016045) | 3.31499025 |
24 | macrophage activation involved in immune response (GO:0002281) | 3.31482616 |
25 | response to muramyl dipeptide (GO:0032495) | 3.17226581 |
26 | NIK/NF-kappaB signaling (GO:0038061) | 3.06366257 |
27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.05313687 |
28 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.02289091 |
29 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.00536540 |
30 | regulation of gamma-delta T cell activation (GO:0046643) | 2.98751628 |
31 | detection of external biotic stimulus (GO:0098581) | 2.96463548 |
32 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91289321 |
33 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.90168490 |
34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87084969 |
35 | regulation of leukocyte degranulation (GO:0043300) | 2.86870403 |
36 | regulation of mast cell degranulation (GO:0043304) | 2.86653623 |
37 | negative regulation of granulocyte differentiation (GO:0030853) | 2.86345530 |
38 | detection of molecule of bacterial origin (GO:0032490) | 2.85441403 |
39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84743355 |
40 | barbed-end actin filament capping (GO:0051016) | 2.84017395 |
41 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.83364971 |
42 | regulation of chemokine biosynthetic process (GO:0045073) | 2.82029897 |
43 | negative regulation of interleukin-12 production (GO:0032695) | 2.81892585 |
44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.81579763 |
45 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.80968527 |
46 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75216534 |
47 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.73803240 |
48 | detection of biotic stimulus (GO:0009595) | 2.71386788 |
49 | regulation of monocyte differentiation (GO:0045655) | 2.69157721 |
50 | immunoglobulin mediated immune response (GO:0016064) | 2.67764933 |
51 | response to type I interferon (GO:0034340) | 2.64160540 |
52 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.61335374 |
53 | negative regulation of interleukin-8 production (GO:0032717) | 2.59595657 |
54 | cellular response to type I interferon (GO:0071357) | 2.59219509 |
55 | type I interferon signaling pathway (GO:0060337) | 2.59219509 |
56 | negative regulation of phagocytosis (GO:0050765) | 2.59029090 |
57 | leukocyte aggregation (GO:0070486) | 2.56532259 |
58 | diacylglycerol metabolic process (GO:0046339) | 2.56062913 |
59 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.55510445 |
60 | apoptotic process involved in morphogenesis (GO:0060561) | 2.53608475 |
61 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.53270914 |
62 | response to laminar fluid shear stress (GO:0034616) | 2.51176063 |
63 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.50986017 |
64 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.44541998 |
65 | regulation of necroptotic process (GO:0060544) | 2.44085490 |
66 | pinocytosis (GO:0006907) | 2.43498809 |
67 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.42947783 |
68 | macrophage activation (GO:0042116) | 2.41462145 |
69 | negative regulation of cell size (GO:0045792) | 2.40193327 |
70 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.39824740 |
71 | thymic T cell selection (GO:0045061) | 2.38314445 |
72 | positive regulation of extracellular matrix organization (GO:1903055) | 2.37442512 |
73 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.36932747 |
74 | histone lysine demethylation (GO:0070076) | 2.35900159 |
75 | B cell receptor signaling pathway (GO:0050853) | 2.35695652 |
76 | histone H3-K9 demethylation (GO:0033169) | 2.34712163 |
77 | myeloid cell activation involved in immune response (GO:0002275) | 2.34581970 |
78 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.34265918 |
79 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.31273223 |
80 | positive regulation of B cell differentiation (GO:0045579) | 2.30643795 |
81 | histone H4 deacetylation (GO:0070933) | 2.30118930 |
82 | protein localization to endosome (GO:0036010) | 2.30081460 |
83 | modulation by symbiont of host cellular process (GO:0044068) | 2.29138163 |
84 | granulocyte activation (GO:0036230) | 2.29027051 |
85 | low-density lipoprotein particle clearance (GO:0034383) | 2.28723125 |
86 | stress fiber assembly (GO:0043149) | 2.28671572 |
87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.27902791 |
88 | regulation of histone H3-K27 methylation (GO:0061085) | 2.27735335 |
89 | regulation of tumor necrosis factor production (GO:0032680) | 2.27453757 |
90 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.27234644 |
91 | neutrophil activation (GO:0042119) | 2.26833510 |
92 | embryonic process involved in female pregnancy (GO:0060136) | 2.26498680 |
93 | regulation of extracellular matrix disassembly (GO:0010715) | 2.25329413 |
94 | regulation of regulated secretory pathway (GO:1903305) | 2.25168122 |
95 | retrograde transport, endosome to Golgi (GO:0042147) | 2.24637074 |
96 | histone demethylation (GO:0016577) | 2.23829791 |
97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.23164152 |
98 | regulation of phagocytosis (GO:0050764) | 2.22839124 |
99 | T cell selection (GO:0045058) | 2.22284854 |
100 | semaphorin-plexin signaling pathway (GO:0071526) | 2.21516616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.31101240 |
2 | MYC_22102868_ChIP-Seq_BL_Human | 2.96712488 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.73145564 |
4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.66026909 |
5 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.61207080 |
6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.55414060 |
7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.54856108 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54114876 |
9 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.46800215 |
10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.44194775 |
11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.33718406 |
12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.30244212 |
13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.28256782 |
14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.20135713 |
15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19197820 |
16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16008461 |
17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.07439851 |
18 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.04733527 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02384316 |
20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94318624 |
21 | MAF_26560356_Chip-Seq_TH1_Human | 1.89965278 |
22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85564397 |
23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84037434 |
24 | MAF_26560356_Chip-Seq_TH2_Human | 1.80412348 |
25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79613876 |
26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78648281 |
27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.75825263 |
28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72143883 |
29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69521892 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62331056 |
31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.61371201 |
32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61353584 |
33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58983308 |
34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56317163 |
35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52836177 |
36 | P68_20966046_ChIP-Seq_HELA_Human | 1.51708310 |
37 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.51373702 |
38 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47135460 |
39 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.46872159 |
40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44734594 |
41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42953672 |
42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41977462 |
43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.40817257 |
44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40475577 |
45 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39967006 |
46 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.39074224 |
47 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36043826 |
48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35230984 |
49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33973845 |
50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33717506 |
51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.32377763 |
52 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32222431 |
53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31792881 |
54 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31401696 |
55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30749029 |
56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30284907 |
57 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29563344 |
58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29453391 |
59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28163770 |
60 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27574521 |
61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27120858 |
62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26922746 |
63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26777974 |
64 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26705530 |
65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26186177 |
66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25468738 |
67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25077565 |
68 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21924463 |
69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21620028 |
70 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21436949 |
71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21412559 |
72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21290718 |
73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21228593 |
74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20224329 |
75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20044114 |
76 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.20030391 |
77 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19511818 |
78 | MYB_26560356_Chip-Seq_TH1_Human | 1.19089723 |
79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17977712 |
80 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.16818048 |
81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16568538 |
82 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15944196 |
83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12629013 |
84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10237708 |
85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10040626 |
86 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08999667 |
87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08501055 |
88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07318820 |
89 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06837482 |
90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06778197 |
91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06612123 |
92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05606672 |
93 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05463623 |
94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04401882 |
95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03881857 |
96 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03215525 |
97 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01611168 |
98 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01114097 |
99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99654677 |
100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99376614 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 3.83339776 |
2 | MP0003436_decreased_susceptibility_to | 3.52267924 |
3 | MP0003303_peritoneal_inflammation | 3.50999450 |
4 | MP0003172_abnormal_lysosome_physiology | 3.00063624 |
5 | MP0003705_abnormal_hypodermis_morpholog | 2.83683342 |
6 | MP0005451_abnormal_body_composition | 2.83664816 |
7 | MP0003724_increased_susceptibility_to | 2.35581420 |
8 | MP0009278_abnormal_bone_marrow | 2.34712657 |
9 | MP0001835_abnormal_antigen_presentation | 2.28579701 |
10 | MP0002419_abnormal_innate_immunity | 2.26187990 |
11 | MP0001849_ear_inflammation | 2.24610014 |
12 | MP0009840_abnormal_foam_cell | 2.14934546 |
13 | MP0005025_abnormal_response_to | 2.09152743 |
14 | MP0005076_abnormal_cell_differentiation | 2.08249898 |
15 | MP0002132_abnormal_respiratory_system | 1.98985919 |
16 | MP0009785_altered_susceptibility_to | 1.97420328 |
17 | MP0008260_abnormal_autophagy | 1.97133418 |
18 | MP0005000_abnormal_immune_tolerance | 1.95055062 |
19 | MP0000685_abnormal_immune_system | 1.91705345 |
20 | MP0000858_altered_metastatic_potential | 1.90065661 |
21 | MP0003300_gastrointestinal_ulcer | 1.89157066 |
22 | MP0010234_abnormal_vibrissa_follicle | 1.86247149 |
23 | MP0004947_skin_inflammation | 1.85644237 |
24 | MP0001790_abnormal_immune_system | 1.83435472 |
25 | MP0005387_immune_system_phenotype | 1.83435472 |
26 | MP0001800_abnormal_humoral_immune | 1.81148172 |
27 | MP0003763_abnormal_thymus_physiology | 1.80490206 |
28 | MP0001533_abnormal_skeleton_physiology | 1.67344900 |
29 | MP0002452_abnormal_antigen_presenting | 1.67253811 |
30 | MP0001819_abnormal_immune_cell | 1.65607044 |
31 | MP0002420_abnormal_adaptive_immunity | 1.65311552 |
32 | MP0002396_abnormal_hematopoietic_system | 1.64834476 |
33 | MP0002723_abnormal_immune_serum | 1.64716768 |
34 | MP0002148_abnormal_hypersensitivity_rea | 1.59759145 |
35 | MP0004510_myositis | 1.59105316 |
36 | MP0006082_CNS_inflammation | 1.56115449 |
37 | MP0003191_abnormal_cellular_cholesterol | 1.55153309 |
38 | MP0010155_abnormal_intestine_physiology | 1.54055756 |
39 | MP0009333_abnormal_splenocyte_physiolog | 1.52835590 |
40 | MP0003453_abnormal_keratinocyte_physiol | 1.52811307 |
41 | MP0005464_abnormal_platelet_physiology | 1.51680097 |
42 | MP0002405_respiratory_system_inflammati | 1.45965458 |
43 | MP0002998_abnormal_bone_remodeling | 1.42873492 |
44 | MP0008004_abnormal_stomach_pH | 1.41446153 |
45 | MP0005397_hematopoietic_system_phenotyp | 1.40255053 |
46 | MP0001545_abnormal_hematopoietic_system | 1.40255053 |
47 | MP0005671_abnormal_response_to | 1.35405680 |
48 | MP0004185_abnormal_adipocyte_glucose | 1.35391756 |
49 | MP0002398_abnormal_bone_marrow | 1.32219802 |
50 | MP0001845_abnormal_inflammatory_respons | 1.25368740 |
51 | MP0000716_abnormal_immune_system | 1.25059505 |
52 | MP0001853_heart_inflammation | 1.22506493 |
53 | MP0005666_abnormal_adipose_tissue | 1.19906976 |
54 | MP0003091_abnormal_cell_migration | 1.18520298 |
55 | MP0002139_abnormal_hepatobiliary_system | 1.15026338 |
56 | MP0003828_pulmonary_edema | 1.13408810 |
57 | MP0008469_abnormal_protein_level | 1.13188209 |
58 | MP0001873_stomach_inflammation | 1.12149470 |
59 | MP0003566_abnormal_cell_adhesion | 1.11873664 |
60 | MP0000678_abnormal_parathyroid_gland | 1.11370128 |
61 | MP0003075_altered_response_to | 1.10754520 |
62 | MP0002722_abnormal_immune_system | 1.09681664 |
63 | MP0002429_abnormal_blood_cell | 1.08044252 |
64 | MP0002254_reproductive_system_inflammat | 1.06599375 |
65 | MP0000537_abnormal_urethra_morphology | 1.05077647 |
66 | MP0003656_abnormal_erythrocyte_physiolo | 1.04324124 |
67 | MP0004381_abnormal_hair_follicle | 1.03769567 |
68 | MP0002933_joint_inflammation | 1.01160234 |
69 | MP0003183_abnormal_peptide_metabolism | 1.00156544 |
70 | MP0000703_abnormal_thymus_morphology | 0.99001679 |
71 | MP0003806_abnormal_nucleotide_metabolis | 0.98250517 |
72 | MP0005409_darkened_coat_color | 0.97299843 |
73 | MP0004808_abnormal_hematopoietic_stem | 0.95888997 |
74 | MP0004858_abnormal_nervous_system | 0.94332675 |
75 | MP0000689_abnormal_spleen_morphology | 0.92052862 |
76 | MP0004264_abnormal_extraembryonic_tissu | 0.91501871 |
77 | MP0002796_impaired_skin_barrier | 0.90932793 |
78 | MP0002166_altered_tumor_susceptibility | 0.90064913 |
79 | MP0005360_urolithiasis | 0.89460939 |
80 | MP0000490_abnormal_crypts_of | 0.88442835 |
81 | MP0005375_adipose_tissue_phenotype | 0.87000038 |
82 | MP0005166_decreased_susceptibility_to | 0.86484668 |
83 | MP0005390_skeleton_phenotype | 0.84740028 |
84 | MP0000465_gastrointestinal_hemorrhage | 0.83720056 |
85 | MP0003448_altered_tumor_morphology | 0.83716559 |
86 | MP0005365_abnormal_bile_salt | 0.83455524 |
87 | MP0009764_decreased_sensitivity_to | 0.76874042 |
88 | MP0003795_abnormal_bone_structure | 0.76505259 |
89 | MP0001851_eye_inflammation | 0.75951724 |
90 | MP0000747_muscle_weakness | 0.75468749 |
91 | MP0000767_abnormal_smooth_muscle | 0.73233305 |
92 | MP0008438_abnormal_cutaneous_collagen | 0.73073231 |
93 | MP0005023_abnormal_wound_healing | 0.71730118 |
94 | MP0003690_abnormal_glial_cell | 0.71363590 |
95 | MP0000609_abnormal_liver_physiology | 0.71157853 |
96 | MP0005621_abnormal_cell_physiology | 0.70126184 |
97 | MP0009931_abnormal_skin_appearance | 0.69928733 |
98 | MP0002138_abnormal_hepatobiliary_system | 0.69621330 |
99 | MP0000343_altered_response_to | 0.68612739 |
100 | MP0000604_amyloidosis | 0.66912776 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 3.72150912 |
2 | Dysostosis multiplex (HP:0000943) | 3.20137404 |
3 | Colitis (HP:0002583) | 3.14147130 |
4 | Abnormality of macrophages (HP:0004311) | 3.13780909 |
5 | Recurrent abscess formation (HP:0002722) | 2.98301393 |
6 | Myositis (HP:0100614) | 2.94064187 |
7 | Deep venous thrombosis (HP:0002625) | 2.90513229 |
8 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.82613773 |
9 | Recurrent bacterial skin infections (HP:0005406) | 2.80016143 |
10 | Thoracic kyphosis (HP:0002942) | 2.78029478 |
11 | Thin bony cortex (HP:0002753) | 2.75423396 |
12 | Increased IgE level (HP:0003212) | 2.75415073 |
13 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.74986460 |
14 | Mucopolysacchariduria (HP:0008155) | 2.74986460 |
15 | Hemorrhage of the eye (HP:0011885) | 2.73824046 |
16 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68878693 |
17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68878693 |
18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68878693 |
19 | Gastrointestinal inflammation (HP:0004386) | 2.61492987 |
20 | Gastrointestinal infarctions (HP:0005244) | 2.59112752 |
21 | Orchitis (HP:0100796) | 2.58960558 |
22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.56526210 |
23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.56526210 |
24 | Abnormality of glycolipid metabolism (HP:0010969) | 2.56526210 |
25 | Nuclear cataract (HP:0100018) | 2.56434466 |
26 | Loss of speech (HP:0002371) | 2.55984803 |
27 | Chronic obstructive pulmonary disease (HP:0006510) | 2.55746750 |
28 | Obstructive lung disease (HP:0006536) | 2.55746750 |
29 | Abnormality of the thoracic spine (HP:0100711) | 2.54065814 |
30 | Systemic lupus erythematosus (HP:0002725) | 2.48512932 |
31 | Mediastinal lymphadenopathy (HP:0100721) | 2.46597324 |
32 | Inflammation of the large intestine (HP:0002037) | 2.41888124 |
33 | Cellulitis (HP:0100658) | 2.35885953 |
34 | Cervical subluxation (HP:0003308) | 2.35851087 |
35 | Metaphyseal cupping (HP:0003021) | 2.32937276 |
36 | Cerebral aneurysm (HP:0004944) | 2.31043859 |
37 | Broad face (HP:0000283) | 2.30678403 |
38 | Granulocytopenia (HP:0001913) | 2.30562101 |
39 | Polygenic inheritance (HP:0010982) | 2.29345584 |
40 | Gingivitis (HP:0000230) | 2.21137487 |
41 | Recurrent viral infections (HP:0004429) | 2.20745428 |
42 | Meningitis (HP:0001287) | 2.20079052 |
43 | Increased cerebral lipofuscin (HP:0011813) | 2.19175223 |
44 | J-shaped sella turcica (HP:0002680) | 2.19068519 |
45 | Optic neuritis (HP:0100653) | 2.18558486 |
46 | Retrobulbar optic neuritis (HP:0100654) | 2.18558486 |
47 | Flat acetabular roof (HP:0003180) | 2.15081008 |
48 | Hypertriglyceridemia (HP:0002155) | 2.13491775 |
49 | Asymmetry of the thorax (HP:0001555) | 2.11715567 |
50 | Increased serum ferritin (HP:0003281) | 2.11223687 |
51 | Recurrent fungal infections (HP:0002841) | 2.09209270 |
52 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01564370 |
53 | Prolonged bleeding time (HP:0003010) | 2.00651606 |
54 | Protrusio acetabuli (HP:0003179) | 1.97535832 |
55 | Abnormality of complement system (HP:0005339) | 1.97369026 |
56 | Abnormality of the columella (HP:0009929) | 1.97145071 |
57 | Obstructive sleep apnea (HP:0002870) | 1.96379385 |
58 | Glomerulonephritis (HP:0000099) | 1.95779871 |
59 | Pustule (HP:0200039) | 1.95296048 |
60 | Abnormality of the lumbar spine (HP:0100712) | 1.93467324 |
61 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92248446 |
62 | Vasculitis (HP:0002633) | 1.91248584 |
63 | Purpura (HP:0000979) | 1.91222418 |
64 | Amyloidosis (HP:0011034) | 1.90419842 |
65 | Spontaneous hematomas (HP:0007420) | 1.90266443 |
66 | Biconcave vertebral bodies (HP:0004586) | 1.87554039 |
67 | Spinal cord lesions (HP:0100561) | 1.86518100 |
68 | Syringomyelia (HP:0003396) | 1.86518100 |
69 | Peritonitis (HP:0002586) | 1.84690380 |
70 | Hepatosplenomegaly (HP:0001433) | 1.83726347 |
71 | Axonal loss (HP:0003447) | 1.83349384 |
72 | Slow saccadic eye movements (HP:0000514) | 1.83105681 |
73 | Easy fatigability (HP:0003388) | 1.83059030 |
74 | Thrombocytosis (HP:0001894) | 1.82665860 |
75 | Epistaxis (HP:0000421) | 1.81330481 |
76 | Hyperacusis (HP:0010780) | 1.80850009 |
77 | Abnormality of the fingertips (HP:0001211) | 1.80633195 |
78 | Interstitial pulmonary disease (HP:0006530) | 1.80197702 |
79 | Vertebral compression fractures (HP:0002953) | 1.79629584 |
80 | Elevated alkaline phosphatase (HP:0003155) | 1.78260921 |
81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78199252 |
82 | Joint stiffness (HP:0001387) | 1.76933441 |
83 | Restrictive lung disease (HP:0002091) | 1.76871357 |
84 | Asymmetric septal hypertrophy (HP:0001670) | 1.75590394 |
85 | Emphysema (HP:0002097) | 1.75008644 |
86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74827288 |
87 | Arterial thrombosis (HP:0004420) | 1.73863383 |
88 | Premature rupture of membranes (HP:0001788) | 1.73442859 |
89 | Viral hepatitis (HP:0006562) | 1.72394823 |
90 | Complement deficiency (HP:0004431) | 1.72229857 |
91 | Recurrent skin infections (HP:0001581) | 1.71802464 |
92 | Aneurysm (HP:0002617) | 1.71333084 |
93 | Chest pain (HP:0100749) | 1.70712335 |
94 | Malnutrition (HP:0004395) | 1.70006366 |
95 | Abnormality of the peritoneum (HP:0002585) | 1.68683403 |
96 | Dilatation of the ascending aorta (HP:0005111) | 1.67026576 |
97 | Blue sclerae (HP:0000592) | 1.66734610 |
98 | Pulmonary embolism (HP:0002204) | 1.66650950 |
99 | Hemoptysis (HP:0002105) | 1.65959453 |
100 | Stridor (HP:0010307) | 1.65776993 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.48761483 |
2 | ERN1 | 3.63970827 |
3 | PRPF4B | 2.69331114 |
4 | RIPK4 | 2.66829763 |
5 | SIK1 | 2.54344798 |
6 | NME2 | 2.52049886 |
7 | SMG1 | 2.49706220 |
8 | MAP4K1 | 2.35592706 |
9 | IRAK3 | 2.21885251 |
10 | FGFR4 | 2.16254455 |
11 | MAP2K3 | 2.13942851 |
12 | ICK | 2.02887397 |
13 | TYK2 | 2.00128099 |
14 | EEF2K | 1.98586649 |
15 | PKN2 | 1.89602740 |
16 | MAP3K14 | 1.88075844 |
17 | TNK2 | 1.82340684 |
18 | MAP3K13 | 1.79314832 |
19 | RIPK1 | 1.70629268 |
20 | IRAK4 | 1.64308053 |
21 | MARK3 | 1.60725466 |
22 | MAP3K10 | 1.59542658 |
23 | CDK12 | 1.58786095 |
24 | BLK | 1.55580354 |
25 | TAOK1 | 1.55375401 |
26 | TBK1 | 1.50601666 |
27 | ZAP70 | 1.49280466 |
28 | CDC42BPA | 1.47918118 |
29 | MATK | 1.44360643 |
30 | MAP3K3 | 1.35140020 |
31 | CSK | 1.33622525 |
32 | FGR | 1.28978033 |
33 | SIK2 | 1.23334384 |
34 | GRK6 | 1.23026154 |
35 | SIK3 | 1.21997827 |
36 | MAP3K1 | 1.19946266 |
37 | IRAK2 | 1.19817416 |
38 | MARK2 | 1.19150813 |
39 | PTK6 | 1.18558347 |
40 | BTK | 1.09138881 |
41 | PDGFRA | 1.09122505 |
42 | TAOK2 | 1.08042273 |
43 | EPHB1 | 1.03960481 |
44 | JAK3 | 1.00875297 |
45 | DDR2 | 0.93697100 |
46 | FES | 0.91287104 |
47 | PDPK1 | 0.90184809 |
48 | HCK | 0.87542993 |
49 | PRKD2 | 0.86732429 |
50 | MST1R | 0.85466083 |
51 | MAP3K6 | 0.84911345 |
52 | MTOR | 0.84637190 |
53 | PAK4 | 0.83911020 |
54 | KSR2 | 0.83451158 |
55 | MAP3K11 | 0.80075532 |
56 | NEK2 | 0.77284368 |
57 | CSF1R | 0.74929755 |
58 | FGFR3 | 0.74426134 |
59 | RET | 0.71261149 |
60 | IKBKE | 0.70991333 |
61 | RPS6KL1 | 0.70722120 |
62 | RPS6KC1 | 0.70722120 |
63 | BMX | 0.70392053 |
64 | JAK1 | 0.68417952 |
65 | CDK4 | 0.67916169 |
66 | MAP3K7 | 0.65755976 |
67 | PRKG2 | 0.63011881 |
68 | TESK1 | 0.62972532 |
69 | RPS6KA2 | 0.62634619 |
70 | HIPK2 | 0.61125949 |
71 | TYRO3 | 0.59904543 |
72 | PDK1 | 0.59865767 |
73 | JAK2 | 0.58482352 |
74 | MAP2K6 | 0.57652217 |
75 | LRRK2 | 0.54591526 |
76 | MAPK12 | 0.54483179 |
77 | LYN | 0.52078789 |
78 | MAPK11 | 0.51972846 |
79 | SYK | 0.49946044 |
80 | TTN | 0.49633438 |
81 | KIT | 0.46899309 |
82 | LCK | 0.46544214 |
83 | RPS6KA6 | 0.45894132 |
84 | MOS | 0.45857730 |
85 | PDGFRB | 0.43338827 |
86 | MAP3K8 | 0.43303864 |
87 | STK38 | 0.41763772 |
88 | LATS2 | 0.41019433 |
89 | IKBKB | 0.40981847 |
90 | TESK2 | 0.39823082 |
91 | MELK | 0.39360308 |
92 | CDK6 | 0.39019531 |
93 | RPS6KA1 | 0.35927547 |
94 | MAPKAPK2 | 0.34909015 |
95 | ITK | 0.34556032 |
96 | MAP2K2 | 0.33752483 |
97 | CDK7 | 0.32212955 |
98 | MAPK7 | 0.31714802 |
99 | PTK2 | 0.30629931 |
100 | IRAK1 | 0.29744241 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.97488745 |
2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30195167 |
3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.28703405 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16088802 |
5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.13978660 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92286957 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89212254 |
8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.86205785 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80709582 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66790569 |
11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.59157171 |
12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58969379 |
13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57311769 |
14 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.57153691 |
15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53579246 |
16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47971984 |
17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46492433 |
18 | Tuberculosis_Homo sapiens_hsa05152 | 1.45728069 |
19 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.44997625 |
20 | Influenza A_Homo sapiens_hsa05164 | 1.34424458 |
21 | Hepatitis C_Homo sapiens_hsa05160 | 1.32010593 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30536678 |
23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28889433 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28606074 |
25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27515523 |
26 | Lysosome_Homo sapiens_hsa04142 | 1.26299874 |
27 | Hepatitis B_Homo sapiens_hsa05161 | 1.23484316 |
28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23135068 |
29 | Bladder cancer_Homo sapiens_hsa05219 | 1.22952224 |
30 | Malaria_Homo sapiens_hsa05144 | 1.20749939 |
31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19998838 |
32 | Pertussis_Homo sapiens_hsa05133 | 1.19939183 |
33 | Apoptosis_Homo sapiens_hsa04210 | 1.18428256 |
34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18005757 |
35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.16819244 |
36 | Measles_Homo sapiens_hsa05162 | 1.12990833 |
37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10422131 |
38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03909503 |
39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03891126 |
40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98308841 |
41 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98176583 |
42 | Allograft rejection_Homo sapiens_hsa05330 | 0.97563780 |
43 | Amoebiasis_Homo sapiens_hsa05146 | 0.96298597 |
44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.94585525 |
45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93808339 |
46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93787503 |
47 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92828180 |
48 | Legionellosis_Homo sapiens_hsa05134 | 0.92194046 |
49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91881127 |
50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91408777 |
51 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90415906 |
52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89758262 |
53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89016482 |
54 | Prostate cancer_Homo sapiens_hsa05215 | 0.87506349 |
55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86725432 |
56 | Prion diseases_Homo sapiens_hsa05020 | 0.85830695 |
57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85808926 |
58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84969894 |
59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84663559 |
60 | Phagosome_Homo sapiens_hsa04145 | 0.84555763 |
61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83747641 |
62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83225471 |
63 | Insulin resistance_Homo sapiens_hsa04931 | 0.82698706 |
64 | Platelet activation_Homo sapiens_hsa04611 | 0.82397648 |
65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79993443 |
66 | Shigellosis_Homo sapiens_hsa05131 | 0.79631741 |
67 | Salmonella infection_Homo sapiens_hsa05132 | 0.79087185 |
68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78868725 |
69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78672815 |
70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77646716 |
71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74086681 |
72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72654714 |
73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72457735 |
74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71470274 |
75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70859032 |
76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69832325 |
77 | Glioma_Homo sapiens_hsa05214 | 0.68434521 |
78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67641622 |
79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66711072 |
80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65181700 |
81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65110077 |
82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63538350 |
83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62879699 |
84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62077089 |
85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58007798 |
86 | Endocytosis_Homo sapiens_hsa04144 | 0.57125914 |
87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55985675 |
88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55108176 |
89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54151351 |
90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53867605 |
91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53788479 |
92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53517177 |
93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53502611 |
94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53165640 |
95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52702642 |
96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52615319 |
97 | Focal adhesion_Homo sapiens_hsa04510 | 0.50834666 |
98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50505674 |
99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49858406 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46496819 |